A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial

Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occur...

Full description

Bibliographic Details
Published in:European Geriatric Medicine
Main Authors: Simal, Ine, Somers, Annemie, Amrouch, Cheïma, Capiau, Andreas, Cherubini, Antonio, Cruz-Jentoft, Alfonso J., Gudmundsson, Adalsteinn, Soiza, Roy L., O'Mahony, Denis, Petrovic, Mirko
Format: Article in Journal/Newspaper
Language:English
Published: 2024
Subjects:
Online Access:https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV
http://hdl.handle.net/1854/LU-01J4ADGXG6MKBEW1FNT8Z4BWYV
https://doi.org/10.1007/s41999-024-01025-7
https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV/file/01J4ADS65GCCYRT9DF5JJSE1J0
_version_ 1830568404797358080
author Simal, Ine
Somers, Annemie
Amrouch, Cheïma
Capiau, Andreas
Cherubini, Antonio
Cruz-Jentoft, Alfonso J.
Gudmundsson, Adalsteinn
Soiza, Roy L.
O'Mahony, Denis
Petrovic, Mirko
author_facet Simal, Ine
Somers, Annemie
Amrouch, Cheïma
Capiau, Andreas
Cherubini, Antonio
Cruz-Jentoft, Alfonso J.
Gudmundsson, Adalsteinn
Soiza, Roy L.
O'Mahony, Denis
Petrovic, Mirko
author_sort Simal, Ine
collection Ghent University Academic Bibliography
container_title European Geriatric Medicine
description Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Methods The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. Results At baseline (median age: 78 [72,84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥2 potassium reducing drugs (17.1%), ≥3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p=0.013). A higher prevalence of new onset falls (p=0.013), major constipation (p=0.004), and major serum electrolyte disturbances (p=0.006) was observed in patients with related and thus potentially causal DDIs. Conclusions Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended.
format Article in Journal/Newspaper
genre Iceland
genre_facet Iceland
id ftunivgent:oai:archive.ugent.be:01J4ADGXG6MKBEW1FNT8Z4BWYV
institution Open Polar
language English
op_collection_id ftunivgent
op_doi https://doi.org/10.1007/s41999-024-01025-7
op_relation https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV
https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV/file/01J4ADS65GCCYRT9DF5JJSE1J0
op_rights No license (in copyright)
op_source EUROPEAN GERIATRIC MEDICINE
ISSN: 1878-7649
ISSN: 1878-7657
publishDate 2024
record_format openpolar
spelling ftunivgent:oai:archive.ugent.be:01J4ADGXG6MKBEW1FNT8Z4BWYV 2025-04-27T14:31:46+00:00 A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial Simal, Ine Somers, Annemie Amrouch, Cheïma Capiau, Andreas Cherubini, Antonio Cruz-Jentoft, Alfonso J. Gudmundsson, Adalsteinn Soiza, Roy L. O'Mahony, Denis Petrovic, Mirko 2024 application/pdf https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV http://hdl.handle.net/1854/LU-01J4ADGXG6MKBEW1FNT8Z4BWYV https://doi.org/10.1007/s41999-024-01025-7 https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV/file/01J4ADS65GCCYRT9DF5JJSE1J0 eng eng https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV/file/01J4ADS65GCCYRT9DF5JJSE1J0 No license (in copyright) EUROPEAN GERIATRIC MEDICINE ISSN: 1878-7649 ISSN: 1878-7657 Medicine and Health Sciences Adverse drug reactions drug-drug-interactions older adults multimorbidity polypharmacy ELDERLY-PATIENTS GERIATRIC CONDITIONS RISK PREVALENCE COHORT NUMBER journalArticle info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2024 ftunivgent https://doi.org/10.1007/s41999-024-01025-7 2025-04-01T06:39:02Z Purpose Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. Methods The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. Results At baseline (median age: 78 [72,84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥2 potassium reducing drugs (17.1%), ≥3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p=0.013). A higher prevalence of new onset falls (p=0.013), major constipation (p=0.004), and major serum electrolyte disturbances (p=0.006) was observed in patients with related and thus potentially causal DDIs. Conclusions Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended. Article in Journal/Newspaper Iceland Ghent University Academic Bibliography European Geriatric Medicine
spellingShingle Medicine and Health Sciences
Adverse drug reactions
drug-drug-interactions
older adults
multimorbidity
polypharmacy
ELDERLY-PATIENTS
GERIATRIC CONDITIONS
RISK
PREVALENCE
COHORT
NUMBER
Simal, Ine
Somers, Annemie
Amrouch, Cheïma
Capiau, Andreas
Cherubini, Antonio
Cruz-Jentoft, Alfonso J.
Gudmundsson, Adalsteinn
Soiza, Roy L.
O'Mahony, Denis
Petrovic, Mirko
A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial
title A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial
title_full A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial
title_fullStr A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial
title_full_unstemmed A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial
title_short A descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the SENATOR trial
title_sort descriptive analysis of drug‑drug interactions and corresponding adverse drug reactions in multimorbid older inpatients : findings from the senator trial
topic Medicine and Health Sciences
Adverse drug reactions
drug-drug-interactions
older adults
multimorbidity
polypharmacy
ELDERLY-PATIENTS
GERIATRIC CONDITIONS
RISK
PREVALENCE
COHORT
NUMBER
topic_facet Medicine and Health Sciences
Adverse drug reactions
drug-drug-interactions
older adults
multimorbidity
polypharmacy
ELDERLY-PATIENTS
GERIATRIC CONDITIONS
RISK
PREVALENCE
COHORT
NUMBER
url https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV
http://hdl.handle.net/1854/LU-01J4ADGXG6MKBEW1FNT8Z4BWYV
https://doi.org/10.1007/s41999-024-01025-7
https://biblio.ugent.be/publication/01J4ADGXG6MKBEW1FNT8Z4BWYV/file/01J4ADS65GCCYRT9DF5JJSE1J0